Mantle Cell Lymphoma synonyms

Mantle Cell Lymphoma (MCL) is a rare, aggressive form of B-cell non-Hodgkin lymphoma officially classified under the WHO classification of tumors of hematopoietic and lymphoid tissues. While "Mantle Cell Lymphoma" is the universally accepted clinical term, you may encounter historical synonyms in older medical records or international literature, such as centrocytic lymphoma or intermediate lymphocytic lymphoma.

Why does Mantle Cell Lymphoma have different names?

The nomenclature for Mantle Cell Lymphoma has evolved significantly due to advances in immunophenotyping and genetic research. Before the 1990s, clinicians struggled to classify this disease, leading to various descriptive names based on how the cells appeared under a microscope. As we gained a better understanding of the translocation t(11;14)(q13;q32) that defines the disease, the medical community standardized the terminology to Mantle Cell Lymphoma to reflect its origin in the mantle zone of the lymph node.

What are the historical and alternative names for Mantle Cell Lymphoma?

If you are reviewing older pathology reports or international medical literature, you may see the following terms used to describe Mantle Cell Lymphoma:

• Centrocytic lymphoma: A term frequently used in the Kiel classification system.


• Intermediate lymphocytic lymphoma: Used in the Working Formulation classification.


• Mantle zone lymphoma: An older descriptive term for the cell of origin.


• Blastic variant of Mantle Cell Lymphoma: A specific, more aggressive subtype often noted separately in clinical reports.

How is Mantle Cell Lymphoma classified today?

In modern clinical practice, Mantle Cell Lymphoma is the standard name used in the International Classification of Diseases (ICD-10/11) and by the World Health Organization (WHO). Using the official name Mantle Cell Lymphoma is crucial for accessing the most current clinical trials, targeted therapies like BTK inhibitors, and patient support resources. Orphanet lists the condition under the code ORPHA:527, ensuring global consistency for researchers and clinicians alike.

Next steps

• Confirm your diagnosis by requesting a pathology report that specifically identifies the t(11;14) translocation and cyclin D1 overexpression.


• Consult with a hematologist-oncologist who specializes in B-cell malignancies.


• Join the DiseaseMaps.org community to connect with other patients and caregivers navigating a diagnosis of Mantle Cell Lymphoma.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• Orphanet: Mantle Cell Lymphoma (ORPHA:527)


• NIH Genetic and Rare Diseases Information Center (GARD)


• World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues


• The Lymphoma Research Foundation (LRF)